LAWSUITS NEWS & LEGAL INFORMATION
Proton Pump Inhibitors Linked with Higher Rates of Gastric Cancer
Santa Cruz, CA: A new study on the use of proton pump inhibitors (PPI) in patients who have been treated successfully for Helicobacter pylori shows that the drugs more than double the risk for gastric cancer.
The study does have several limitations, including the fact that it is observational and was done in Hong Kong, where there are well recognized specific risks for gastric cancer in Asian patients, including diet and high rates of H. pylori.
However, according to the authors of the study, published online in Gut, on October 31, the results show a "clear dose-response and time-response" trend in PPI use and gastric cancer. Therefore, they state, the risk observed suggests the need for "caution when prescribing long-term PPIs to these patients even after successful eradication of H. pylori."
Led by Wai Keung Leung, MBChB, MD, from Queen Mary Hospital, Hong Kong, the study looked at H. pylori infection and its relationship with gastric cancer, among other outcomes. They found a greater associated risk for gastric cancer with longer duration and more frequent use of PPIs.
Despite the study’s limitations, Dr Leung and colleagues state that, to their knowledge, "this is the first study to demonstrate that long-term PPIs use, even after H. pylori eradication therapy, is still associated with an increased risk of gastric cancer. This is likely related to the profound acid suppression of PPIs that worsens atrophic gastritis, particularly in those patients with established gastric atrophy as a result of chronic H. pylori-induced inflammation."
Last updated on
FREE PROTON PUMP INHIBITOR GASTRIC CANCER LAWSUIT EVALUATION
Send your Proton Pump Inhibitor Gastric Cancer claim to a lawyer who will review your claim at NO COST or obligation.
GET LEGAL HELP NOW
GET LEGAL HELP NOW
Proton Pump Inhibitors Gastric Cancer Risk
However, according to the authors of the study, published online in Gut, on October 31, the results show a "clear dose-response and time-response" trend in PPI use and gastric cancer. Therefore, they state, the risk observed suggests the need for "caution when prescribing long-term PPIs to these patients even after successful eradication of H. pylori."
Led by Wai Keung Leung, MBChB, MD, from Queen Mary Hospital, Hong Kong, the study looked at H. pylori infection and its relationship with gastric cancer, among other outcomes. They found a greater associated risk for gastric cancer with longer duration and more frequent use of PPIs.
Despite the study’s limitations, Dr Leung and colleagues state that, to their knowledge, "this is the first study to demonstrate that long-term PPIs use, even after H. pylori eradication therapy, is still associated with an increased risk of gastric cancer. This is likely related to the profound acid suppression of PPIs that worsens atrophic gastritis, particularly in those patients with established gastric atrophy as a result of chronic H. pylori-induced inflammation."
Legal Help
If you or a loved one has suffered similar damages or injuries, please fill in our form and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.Last updated on
PROTON PUMP INHIBITOR GASTRIC CANCER LEGAL ARTICLES AND INTERVIEWS
Proton Pump Inhibitors – More Harm than Good, especially in COVID-19 Patients
Santa Clara, CA Over the past several years, Proton Pump Inhibitors (PPI) have been linked to serious health complications. And more recent studies indicate that these acid reflux drugs do more harm than good. One such study opines that PPI exposure increases mortality in COVID-19 patients. Other studies suggest PPIs can damage major organs and regular use of PPI is linked to a higher risk of being diagnosed with type 2 diabetes and serious skin reactions such as life-threatening Stevens-Johnson Syndrome. And there is more…
READ MORE
“Acid Reflux Drugs Caused my Type 2 Diabetes”
Phoenix, AZ Ten years ago Gary Phillips was diagnosed with type 2 diabetes. He had taken proton pump inhibitor (PPI) medications for acid reflux issues at least once a day for about 13 years but only knew that the medications were linked to diabetes when he read about PPI lawsuits. Unfortunately the meds worked— so he kept taking them. Now he takes insulin shots.
READ MORE
Regular Acid-reflux Drug Use Linked to Higher Risk of type 2 Diabetes
Santa Clara, CA During this Pandemic there is also an epidemic that has been growing for decades and it is just as dangerous, perhaps even more so, than COVID 19. And drugs known as proton pump inhibitors or PPIs are feeding this epidemic: type 2 diabetes.
READ MORE

December 31, 2020
READ MORE
“Acid Reflux Drugs Caused my Type 2 Diabetes”

November 28, 2020
READ MORE
Regular Acid-reflux Drug Use Linked to Higher Risk of type 2 Diabetes

October 25, 2020
READ MORE
READ MORE Proton Pump Inhibitor Settlements and Legal News
READ MORE Drugs/Medical Settlements and Legal News
READ MORE Personal Injury Settlements and Legal News
READ MORE Drugs/Medical Settlements and Legal News
READ MORE Personal Injury Settlements and Legal News
READER COMMENTS
Melissia Bonds
on
Patricia Letnes Jemison
on